Skip Navigation

AIDSInfo logo

 
Home > Drugs > Racivir

Racivir
  Audio
Drug Class: Nucleoside Reverse Transcriptase Inhibitors
Racivir, also known as RCV, is a type of medicine called a nucleoside reverse transcriptase inhibitor (NRTI). NRTIs work by blocking reverse transcriptase, a protein that HIV needs to make more copies of itself.

HIV/AIDS-Related Uses
Racivir is an investigational medicine that is not yet approved by the FDA for use outside of clinical trials. It is being studied for the treatment of HIV infection as part of a combination regimen. This medicine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people.

Dosage Form/Administration
Racivir comes in tablet form and is taken by mouth once a day. It has not yet been determined whether racivir should be taken with or without food. Racivir is taken in combination with approved antiretroviral medications.

Contraindications
Individuals should tell a doctor about any medical problems before taking this medicine.

Possible Side Effects
Along with its desired effects, racivir may cause some unwanted effects. Although not all of these effects are known, headache and fatigue have been reported.

Drug and Food Interactions
A doctor should be notified of any other medications being taken, including prescription, nonprescription (over-the-counter), or herbal medications.

Clinical Trials
Click here to search ClinicalTrials.gov for trials that use Racivir.

Manufacturer Information
Racivir
  Pharmasset, Inc.
  US Research Operations
  1860 Montreal Road
  Tucker,  GA  30084
  (678) 395-0035
    
Updated May 30, 2007